Merck & Co withdraws antitrust filing on Schering-Plough acquisition
This article was originally published in Scrip
Executive Summary
Merck & Co has withdrawn its initial filing for US antitrust clearance for its proposed $41 billion acquisition of Schering-Plough, the company announced at a Deutsche Bank Healthcare conference.